Mode
Text Size
Log in / Sign up

Arthroscopy-assisted curettage and bone grafting for proximal femur giant cell tumor in a 25-year-old manSingle case report suggests possible approach for treating a rare bone tumor in the hip

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note: Findings from a single case report of GCT treatment are preliminary and uncontrolled.

This is a case report of a 25-year-old man with right hip pain from a giant cell tumor of the proximal femur. The patient underwent lesion curettage and inactivation assisted by hip arthroscopy, followed by reconstruction of the bone defect using a combination of artificial and autologous bone grafting. No comparator procedure was reported.

The authors report that this single case suggests the procedure may facilitate local tumor control and hip joint function preservation. No specific outcome data, effect sizes, statistical measures, or duration of follow-up were provided. Safety and tolerability information, including adverse events, was not reported.

Key limitations include the evidence being from a single patient with no control group, statistical analysis, or reported follow-up data. The outcome is described as a suggestion rather than a definitive result. The authors state this case may serve as a reference for managing similar cases, but its practice relevance is extremely limited due to the preliminary nature of the evidence.

A medical team has shared a detailed report on how they treated a single patient with a rare, non-cancerous bone tumor called a giant cell tumor. The patient was a 25-year-old man with pain in his right hip. The doctors used a small camera (arthroscope) to help guide the removal of the tumor tissue, then filled the resulting cavity with a mix of artificial and the patient's own bone. The goal was to control the tumor while keeping the hip joint working normally.

In this one case, the doctors observed that the procedure seemed to help achieve local control of the tumor and preserve the function of the hip joint. The report did not mention any specific safety problems or side effects from the treatment. It's important to note that the doctors described this as a suggestion of a potential benefit, not a guaranteed outcome.

The main reason to be careful is that this is a report on just one person. There is no comparison to other treatments, no statistical analysis, and no information on how the patient did over a long period of time. Readers should understand that this is an early, descriptive account of a surgical technique used in a very specific situation. It may give other surgeons an idea to consider, but it does not provide evidence that this is the best or only way to treat this condition.

What this means for you:
A single patient's experience suggests a possible surgical technique; it is not proven evidence for treatment.

Study Details

EvidenceLevel 5
PublishedMar 2026
View Original Abstract ↓
Giant cell tumor of bone (GCT) is a borderline primary bone tumor characterized by locally aggressive behavior, for which surgical management is the mainstay of treatment. Reports on GCT involving the proximal femur remain relatively limited. Achieving complete lesion removal while preserving hip joint function continues to represent a clinical challenge. A 25-year-old man presented with right hip pain. Imaging examinations revealed an occupying lesion in the proximal region of the right femur. The patient underwent lesion curettage and inactivation assisted by hip arthroscopy, followed by bone defect reconstruction using a combination of artificial bone and autologous bone grafting. This case suggests that arthroscopy-assisted lesion curettage combined with bone grafting may facilitate local tumor control while preserving hip joint function, and may serve as a reference for the management of similar cases.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.